CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $23.4M, above the global median of $16.24M
- FinancialsAltman Z-Score 4.58: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.47%Below 5Y avg (2.61%)
Annual Rate
JPY 58.00Paid semi-annual
Payout Ratio
51.7%Sustainable
Next Ex-Dividend
Sep 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
81.70BJPY515.63M · vs all stocks (USD)
Trailing P/E
20.47xvs Medical Devices peers
Revenue (TTM)
42.43BJPY267.80M · vs all stocks (USD)
Profit Margin
8.37%vs Medical Devices peers
Beta
0.3140xvs all stocks
52-Week Change
-2.68%vs all stocks
Forward Annual Dividend Yield
2.47%vs all stocks
Market Capitalization
81.70BJPY515.63M · vs all stocks (USD)
Enterprise Value
72.30BJPY456.34M · vs all stocks (USD)
Trailing P/E
20.47xvs Medical Devices peers
Forward P/E
25.10xvs Medical Devices peers
Price to Sales (TTM)
1.78xvs Medical Devices peers
Price to Book (MRQ)
1.74xvs Medical Devices peers
Enterprise to Revenue
1.70xvs Medical Devices peers
Enterprise to EBITDA
13.42xvs Medical Devices peers
Profit Margin
8.37%vs Medical Devices peers
Operating Margin
6.23%vs Medical Devices peers
Return on Assets (TTM)
2.87%vs Medical Devices peers
Return on Equity (TTM)
8.34%vs Medical Devices peers
Revenue (TTM)
42.43BJPY267.80M · vs all stocks (USD)
Revenue per Share (TTM)
1.29KJPYUpdated Aug 20, 2026Quarterly Revenue Growth
5.20%vs Medical Devices peers
Gross Profit (TTM)
16.15BJPY101.94M · vs all stocks (USD)
EBITDA (TTM)
5.41BJPY34.14M · vs all stocks (USD)
Net Income (TTM)
3.55BJPY22.43M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.80%vs Medical Devices peers
Operating Cash Flow (TTM)
4.04BJPY25.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.71BJPY23.40M · vs all stocks (USD)
Forward Annual Dividend Rate
58.00JPYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.47%vs all stocks
Trailing Annual Dividend Rate
58.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.47%vs all stocks
5-Year Average Dividend Yield
2.61%vs all stocks
Payout Ratio
51.75%vs Medical Devices peers
Revenue
41.90BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
25.72BJPYFY2026 · Mar 31, 2026Gross Profit
16.18BJPYFY2026 · Mar 31, 2026Operating Income
2.92BJPY18.43M · vs all stocks (USD)
Pre-tax Income
4.83BJPYFY2026 · Mar 31, 2026Income Tax Expense
1.13BJPYFY2026 · Mar 31, 2026Net Income
3.71BJPYFY2026 · Mar 31, 2026EBIT
4.86BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
5.41BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
17.00MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
29.00MJPYFY2026 · Mar 31, 2026EPS (Basic)
112.52JPYFY2026 · Mar 31, 2026EPS (Diluted)
112.08JPYFY2026 · Mar 31, 2026Basic Shares Outstanding
32.96MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
32.96MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
5.19BJPYFY2026 · Mar 31, 2026Free Cash Flow
-674.00MJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
7.94BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
4.83BJPYFY2026 · Mar 31, 2026Other Non-cash Items
-7.00MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
341.00MJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
26.00MJPYFY2026 · Mar 31, 2026Capital Expenditures
-5.87BJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
-90.00MJPYFY2026 · Mar 31, 2026Net Acquisitions
2.07BJPYFY2026 · Mar 31, 2026Purchase of Investments
-1.58BJPYFY2026 · Mar 31, 2026Sale of Investments
2.24BJPYFY2026 · Mar 31, 2026Other Investing Activity
-201.00MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-3.33BJPYFY2026 · Mar 31, 2026Long-term Debt Issuance
3.00BJPYFY2026 · Mar 31, 2026Long-term Debt Payments
-50.00MJPYFY2026 · Mar 31, 2026Common Stock Repurchase
-1.68BJPYFY2026 · Mar 31, 2026Common Dividends Paid
-1.86BJPYFY2026 · Mar 31, 2026Other Financing Charges
261.00MJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
-322.00MJPYFY2026 · Mar 31, 2026Shares Outstanding
32.97MSharesUpdated Aug 20, 2026Float Shares
26.23MSharesUpdated Aug 20, 2026% Held by Insiders
3.72%vs all stocks
% Held by Institutions
56.56%vs all stocks
Total Cash (MRQ)
9.89BJPY62.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
299.95JPYUpdated Aug 20, 2026Total Debt (MRQ)
5.87BJPY37.08M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1351xvs Medical Devices peers
Current Ratio (MRQ)
2.20xvs Medical Devices peers
Book Value per Share (MRQ)
1.32KJPYUpdated Aug 20, 2026Total Assets
62.65BJPY395.44M · vs all stocks (USD)
Total Current Assets
32.04BJPYFY2026 · Mar 31, 2026Total Liabilities
18.62BJPYFY2026 · Mar 31, 2026Total Non-current Assets
30.61BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
3.99BJPYFY2026 · Mar 31, 2026Total Current Liabilities
14.64BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
10.94BJPYFY2026 · Mar 31, 2026Other Short-term Investments
354.00MJPYFY2026 · Mar 31, 2026Accounts Receivable
10.17BJPYFY2026 · Mar 31, 2026Inventory
7.99BJPYFY2026 · Mar 31, 2026Accounts Payable
4.84BJPYFY2026 · Mar 31, 2026Short-term Debt
3.71BJPYFY2026 · Mar 31, 2026Other Current Liabilities
4.69BJPYFY2026 · Mar 31, 2026Long-term Debt
3.58BJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
343.00MJPYFY2026 · Mar 31, 2026Common Stock (Book)
6.90BJPYFY2026 · Mar 31, 2026Retained Earnings
30.88BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
44.03BJPY277.92M · vs all stocks (USD)
Treasury Stock
2.24BJPYFY2026 · Mar 31, 202652-Week Low
2.02KJPYUpdated Aug 20, 202652-Week High
3.50KJPYUpdated Aug 20, 202652-Week Change
-2.68%vs all stocks
Beta
0.3140xvs all stocks
50-Day MA
2.50KJPYUpdated Aug 20, 2026200-Day MA
2.68KJPYUpdated Aug 20, 2026Avg 10-Day Volume
181.01KSharesUpdated Aug 20, 2026Avg 30-Day Volume
232.79KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
112.05JPYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.58: safe zoneNotable
Altman Z-Score: 4.58
High earnings qualityNotable
Earnings Quality Score: 1.01
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $23.4M, above the global median of $16.24MNotable
Levered free cash flow (USD): 23,403,412.8Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Arvinas Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Aquestive Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lifecome Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zura Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharmicell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Aim Vaccine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
IOL Chemicals and Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Regenxbio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Aim Pharm Inc.
Tier 1ProductionApproval-Gated PipelineRule